About 100 reports

  • Description of Brain Cancer Types
  • 3.5.5 Diagnosed Incident Cases of Brain Cancer by Type

Table ## presents a description of the different types of brain cancer presented in this report.

  • Brain Cancer
  • United Kingdom
  • United States
  • World
  • Forecast

You can request one free hour of our analyst’s time when you purchase this market report.

  • Brain Cancer
  • World
  • Market Size

Global Brain Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Brain Cancer
  • Cancer
  • United States
  • World
  • Forecast

Europe Brain Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Brain Cancer
  • Europe
  • France
  • Germany
  • Forecast

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • France
  • United States
  • Market Size

Brain Tumor Therapeutics: Global Markets to 2023 Chapter ## Introduction Scope of Report Study Goals and Objectives Reasons for Doing This Study Information Sources and Methodology Geographic Breakdown Analyst’s Credentials BCC Custom Research Related BCC Research Reports Chapter ##

  • Brain Cancer
  • Therapy
  • World

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • France
  • Germany
  • Italy
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Japan
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United States
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United Kingdom
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Italy
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • France
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Germany
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Spain
  • Market Size
  • DESCRIPTION OF BRAIN CANCER TYPES
  • 5.5 EPIDEMIOLOGICAL FORECAST FOR BRAIN CANCER (2017-2027)

THE DIFFERENCES IN THE FIVE-YEAR DIAGNOSED PREVALENT CASES OF BRAIN CANCER AMONG THE ##MM ARE DEPENDENT ON THE MARKET-SPECIFIC ONE- TO FIVE-YEAR OBSERVED SURVIVAL PROPORTIONS AND THE INCIDENCE RATE OF BRAIN CANCER.

  • Brain Cancer
  • China
  • United States
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2017(percent)
  • Market Size

BRAIN CANCER IS THE LEADING CAUSE OF CANCER-RELATED Chapter III BRAIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS DEATH IN PATIENTS YOUNGER THAN AGE ##.

  • Brain Cancer
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd
  • Brain Cancer Treatment Drugs Sales Volume
  • Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2017(percent)

SOME BRAIN CANCERS OCCUR WHEN ONE TYPE OF CELL TRANSFORMS FROM ITS NORMAL CHARACTERISTICS.

  • Brain Cancer
  • Demand
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Chapter IV
  • Pricing Trend

Some brain cancers occur when one type of cell transforms from its normal characteristics.

  • Brain Cancer
  • Demand
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Beijing Novartis Pharma Ltd

Increasing prevalence of cancer, brain tumours, and renal cell cancer will boost the market growth.

  • Brain Cancer
  • North America
  • United States
  • World
  • Guerbet Group
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF BRAIN CANCER TO ONCOLOGY CLINICAL TRIALS
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF BRAIN CANCER TO ONCOLOGY CLINICAL TRIALS

Brain Cancer Global Clinical Trials Review, H##, 2018 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: DEC 2018 LIST OF TABLES LIST OF FIGURES Brain Cancer Global Clinical Trials Review, H##, 2018 outlines clinical trials in Brain

  • Brain Cancer
  • Clinical Trial
  • Oncology
  • United States
  • World
  • APR 11, 2017: FEINSTEIN INSTITUTE EXAMINES USE OF ANTIPARASITIC DRUG AS NEW TREATMENT FOR BRAIN TUMORS
  • APR 11, 2017: FEINSTEIN INSTITUTE EXAMINES USE OF AN ANTIPARASITIC DRUG AS NEW TREATMENT FOR BRAIN TUMORS

This agreement enables Novogen and Feinstein Institute to provide treatments for brain cancer.

  • Brain Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Social Conditions
  • LATEST CLINICAL TRIALS NEWS ON BRAIN CANCER
  • BRAIN CANCER THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2017*

Brain Cancer Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: MAY 2017 LIST OF TABLES LIST OF FIGURES Brain Cancer Global Clinical Trials Review, H##, 2017 outlines clinical trials in Brain

  • Brain Cancer
  • Cancer
  • United States
  • World
  • Product Initiative

2019 Brain Cancer Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Brain Cancer
  • Cancer
  • Clinical Trial
  • Drug Development
  • APAC

Strategic initiatives List of Tables ##.

  • Brain Cancer
  • Therapy
  • United States
  • Forecast
  • Market Size

Brain Cancer Pipeline Highlights – 2017 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United States
  • Product Initiative
  • 18.1 Competitive Scenario
  • 05. Introduction

Introduction Glioblastoma multiforme is a variant of brain cancer, and is one of the most aggressive diseases.

  • Brain Cancer
  • Arbor Pharmaceuticals, LLC
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • NANOTHERM - BRAIN CANCER
  • NANOTHERM - BRAIN CANCER - PRODUCT STATUS

Cancer ## Glioblastoma Multiforme ## Pancreatic Cancer ## Prostate Cancer ## Prostate Carcinoma ## Stomach Neoplasm ## Brain Cancer ## MagForce AG Ongoing Clinical Trials by Trial Status Ongoing, Recruiting

  • Brain Cancer
  • Prostate Cancer
  • Germany
  • United States
  • MagForce AG
  • AUG 07, 2017: FDA AWARDS ORPHAN STATUS TO BRAIN CANCER VACCINE DEVELOPED AT ROSWELL PARK CANCER INSTITUTE
  • JUN 13, 2018: IMMUNOTHERAPY VACCINE SHOWS GREAT PROMISE IN TREATING BRAIN CANCER PATIENTS

JUN ##, 2018: IMMUNOTHERAPY VACCINE SHOWS GREAT PROMISE IN TREATING BRAIN CANCER PATIENTS Adding an immunotherapy vaccine to traditional treatment methods is improving outcomes for patients with glioblastoma (GBM), the most aggressive form of brain cancer.

  • Brain Cancer
  • Immunotherapy
  • United States
  • World
  • Product Initiative
  • JUN 13, 2018: IMMUNOTHERAPY VACCINE SHOWS GREAT PROMISE IN TREATING BRAIN CANCER PATIENTS
  • MAY 29, 2018: INTERIM RESULTS FROM CLINICAL TRIAL OF IMMUNOTHERAPY FOR GLIOBLASTOMA SHOW SIGNIFICANT CLINICAL BENEFIT

Stemline Therapeutics is developing SL-## for the treatment of brain cancer.

  • Brain Cancer
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Immunovaccine Inc.
  • Oct 12, 2017: Lenox Hill Hospital participates in clinical research study to test investigational treatment for recurrent brain cancer

Its pipeline products include CX-## a proprietary combination of disulfiram and copper that is in Phase II clinical trial for the treatment of recurrent glioblastoma; and completed Phase ## trial in metastatic prostate cancer and breast cancer.

  • Brain Cancer
  • United States
  • Deals & Alliance
  • Product Initiative
  • Cantex Pharmaceuticals, Inc.